We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+5.27%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$369M
AUM Growth
+$15.7M
Cap. Flow
+$14.7M
Cap. Flow %
3.98%
Top 10 Hldgs %
34.82%
Holding
296
New
4
Increased
274
Reduced
4
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 14.97%
2 Financials 11.53%
3 Communication Services 5.05%
4 Healthcare 4.97%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
176
Allstate
ALL
$70.6B
$382K 0.1%
3,277
+126
+4% +$14.9K
V icon
177
Visa
V
$677B
$381K 0.1%
1,732
+98
+6% +$21K
NUE icon
178
Nucor
NUE
$58.3B
$380K 0.1%
3,323
+158
+5% +$17.3K
SHW icon
179
Sherwin-Williams
SHW
$83.5B
$379K 0.1%
1,182
+87
+8% +$28.1K
XBI icon
180
State Street SPDR S&P Biotech ETF
XBI
$10B
$374K 0.1%
2,880
+83
+3% +$10K
KKR icon
181
KKR & Co
KKR
$89.1B
$361K 0.1%
4,590
+340
+8% +$25.1K
SPLV icon
182
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
$360K 0.1%
5,648
+319
+6% +$20.5K
FSKR
183
DELISTED
FS KKR Capital Corp. II
FSKR
$357K 0.1%
14,515
+949
+7% +$23.3K
MAIN icon
184
Main Street Capital
MAIN
$5.05B
$353K 0.1%
7,746
+297
+4% +$13.1K
NKE icon
185
Nike
NKE
$64.1B
$351K 0.1%
2,096
+41
+2% +$6.76K
VTR icon
186
Ventas
VTR
$47.5B
$351K 0.1%
6,731
+258
+4% +$13.5K
ARKK icon
187
ARK Innovation ETF
ARKK
$5.59B
$350K 0.09%
2,864
+236
+9% +$25.8K
EWG icon
188
iShares MSCI Germany ETF
EWG
$1.56B
$347K 0.09%
10,102
+100
+1% +$3.32K
ORGN
189
DELISTED
Origin Materials
ORGN
$347K 0.09%
1,631
+32
+2% +$6.33K
IVT icon
190
InvenTrust Properties
IVT
$2.79B
$346K 0.09%
+14,119
New +$356K
VUG icon
191
Vanguard Morningstar Growth ETF
VUG
$212B
$346K 0.09%
6,678
+66
+1% +$3.44K
PNFP icon
192
Pinnacle Financial Partners Inc
PNFP
$15.8B
$342K 0.09%
3,472
+133
+4% +$13K
PARA
193
DELISTED
Paramount Global Class B
PARA
$341K 0.09%
9,537
+187
+2% +$6.45K
ACAD icon
194
Acadia Pharmaceuticals
ACAD
$4.51B
$340K 0.09%
19,689
+1,114
+6% +$22.4K
BCRX icon
195
BioCryst Pharmaceuticals
BCRX
$2.42B
$340K 0.09%
25,359
+1,659
+7% +$22K
TAP icon
196
Molson Coors Class B
TAP
$8.02B
$339K 0.09%
7,373
+546
+8% +$25.1K
ARCC icon
197
Ares Capital
ARCC
$13.4B
$337K 0.09%
16,057
+1,050
+7% +$21.8K
CSGP icon
198
CoStar Group
CSGP
$12.2B
$335K 0.09%
4,040
+40
+1% +$3.36K
PG icon
199
Procter & Gamble
PG
$340B
$335K 0.09%
2,335
+23
+1% +$3.42K
NFLX icon
200
Netflix
NFLX
$307B
$331K 0.09%
5,110
+100
+2% +$6.39K

Similar funds

Kalos Management's Q4 2021 Portfolio in Review

As of Q4 2021, Kalos Management held 296 positions worth $369M, up 4.4% from $354M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kalos Management deployed $14.7M of net new capital in Q4 2021, opening 4 new positions and adding to 274 existing holdings. Its largest new stake was CION Investment: 313,841 shares worth $3.96M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $680K trimmed.

  • Kalos Management's largest Q4 2021 buy was CION Investment: 313,841 shares worth $3.96M.
  • Kalos Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $514K increase.
  • Kalos Management's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $680K.
  • Kalos Management fully exited Vale S A in Q4 2021, selling an estimated $683K.
  • Kalos Management's ten largest holdings make up 35% of its $369M portfolio in Q4 2021.
  • Kalos Management opened 4 new positions and closed 14 in Q4 2021.
  • Kalos Management's portfolio value rose 4.4% quarter-over-quarter to $369M.

Based on Kalos Management's 13F filing for Q4 2021, filed 3 Feb 2022.